Cosmos Health Inc.COSMEarnings & Financial Report
AgniKul Cosmos Private Limited is a private Indian aerospace manufacturer and commercial launch service provider based in National Centre for Combustion Research and Development (NCCRD) of IIT Madras, Chennai. The start up aims to develop and launch its own small-lift launch vehicle such as the Agnibaan, capable of placing 100 kg (220 lb) payload into a 700 km (430 mi) orbit.
Revenue
$14.7M
Gross Profit
$1.2M
Operating Profit
$-2.6M
Net Profit
$-2.8M
Gross Margin
7.9%
Operating Margin
-17.9%
Net Margin
-19.2%
YoY Growth
11.7%
EPS
$-0.10
Financial Flow
Cosmos Health Inc. Q2 2025 Financial Summary
Cosmos Health Inc. reported revenue of $14.7M (up 11.7% YoY) for Q2 2025, with a net profit of $-2.8M (down 9.2% YoY) (-19.2% margin). Cost of goods sold was $13.6M, operating expenses totaled $3.8M.
Key Financial Metrics
| Total Revenue | $14.7M |
|---|---|
| Net Profit | $-2.8M |
| Gross Margin | 7.9% |
| Operating Margin | -17.9% |
| Report Period | Q2 2025 |
Cosmos Health Inc. Annual Revenue by Year
Cosmos Health Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $65.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $65.3M |
| 2024 | $54.4M |
| 2023 | $53.4M |
| 2022 | $50.3M |
Cosmos Health Inc. Quarterly Revenue & Net Profit History
Cosmos Health Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $19.7M | +38.5% | $-10.1M | -51.5% |
| Q3 2025 | $17.1M | +37.9% | $-5.4M | -31.3% |
| Q2 2025 | $14.7M | +11.7% | $-2.8M | -19.2% |
| Q1 2025 | $13.7M | -6.0% | $-818.1K | -6.0% |
| Q4 2024 | $14.2M | -10.2% | $-3.3M | -23.5% |
| Q3 2024 | $12.4M | -3.2% | $-8.4M | -67.5% |
| Q2 2024 | $13.2M | +6.8% | $-2.6M | -19.6% |
| Q1 2024 | $14.6M | +18.1% | $-1.9M | -12.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.6M | $13.2M | $12.4M | $14.2M | $13.7M | $14.7M | $17.1M | $19.7M |
| YoY Growth | 18.1% | 6.8% | -3.2% | -10.2% | -6.0% | 11.7% | 37.9% | 38.5% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $62.3M | $60.8M | $64.5M | $54.3M | $57.2M | $61.8M | $69.5M | $65.5M |
| Liabilities | $27.8M | $28.7M | $29.5M | $29.8M | $31.2M | $35.6M | $46.4M | $47.1M |
| Equity | $34.5M | $32.1M | $35.0M | $24.5M | $26.0M | $26.2M | $23.1M | $18.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.4M | $-1.2M | $739774 | $-3.8M | $-186316 | $-1.2M | $-2.5M | $-4.6M |